Editas Medicine (United States)
Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Editas Medicine (United States), United States, covering academic research published from 2012 to 2024. Read More.
Open Access Percentage
64%
Total
Publications
152
Total Open
Publications
97
Total
Citations
12K
Open Access
Percentage
64%
Total
Publications
152
Total Open
Publications
97
Total
Citations
12K
Breakdown
Publisher Open
13%
Both
39%
Other Platform Open
10%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
27
Hybrid 19%
14
No Guarantees 45%
34
Other Platform Open
Domain 89%
64
Institution 11%
8
Other Internet 10%
7
Public 3%
2
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 64 |
DOI | Other Internet | 7 |
Europe PMC | Domain | 3 |
Figshare | Public | 2 |
DASH - Digital Access to Scholarship at Harvard | Institution | 2 |
DANS - Data Archiving and Networked Services | Institution | 2 |
University of Turin - Institutional Research Information System University of Turin | Institution | 1 |
University of Dundee - Discovery Research Portal | Institution | 1 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 1 |